OAKLAND, CA

and

TORONTO

,

Dec. 30, 2021

/PRNewswire/ – Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR) (OTCQX: HBORF), a

California

-focused, vertically-integrated cannabis enterprise, today announced the resignation of

Michael Dacks

from its board of directors (“Board”), effective

December 31, 2021

. Mr. Dacks is leaving to pursue other opportunities as Harborside prepares to reconstitute its Board in 2022, following the closing of the acquisitions (the “Transactions”) of LPF JV Corporation (“Loudpack”) and UL Holdings Inc. (“Urbn Leaf”) to create StateHouse Holdings, as announced in the Company’s press release dated

November 29, 2021

.

“On behalf of the entire Board and management team, I want to thank Mike for his significant contributions to Harborside,” said

Matthew Hawkins

, Chair of the Board and Interim CEO. “Since joining the Board in

November 2020

, Mike has played a crucial role in strengthening Harborside’s competitive position. This has culminated in agreements to acquire Loudpack and Urbn Leaf to create StateHouse Holdings upon closing of the Transactions, which we expect will be a leading

California

cannabis company. We wish Mike the best in his future endeavors as we work to complete these transformational acquisitions.”

“It’s been a pleasure to participate in another milestone industry transaction,” said Mr. Dacks. “The bench strength, depth of experience and engagement on the Board since it was refreshed 12 months ago, is something truly rare in our industry. Once Harborside completes its pending business combination with Loudpack and Urbn Leaf to create StateHouse Holdings, the Company will be positioned to create a pre-eminent vertically-integrated

California

cannabis powerhouse.”

For the latest news, activities, and media coverage, please visit the Harborside corporate website at



http://www.investharborside.com



or connect with us on



LinkedIn



,



Facebook



, and



Twitter



.

About Harborside:

Harborside, a vertically integrated enterprise with cannabis licenses covering retail, distribution, cultivation, nursery and manufacturing, is one of the oldest and most respected cannabis companies in the world. Founded in

California

in 2006, Harborside was awarded one of the first six medical cannabis licenses granted in

the United States

. Today, the company operates three major dispensaries in the

San Francisco Bay Area

, a dispensary in the

Palm Springs

area outfitted with

Southern California’s

only cannabis drive-thru window, a dispensary in

Oregon

, a manufacturing facility in

Oakland, California

, distribution facilities in

San Jose

and

Los Angeles, California

and an integrated cultivation/production facility in

Salinas

, California.  Harborside is a publicly listed company, trading on the Canadian Securities Exchange (“CSE”) under the ticker symbol “HBOR” and the OTCQX under the ticker symbol “HBORF”, and the Company continues to play an instrumental role in making cannabis safe and accessible to a broad and diverse community of

California

and

Oregon

consumers. Additional information regarding Harborside is available under Harborside’s SEDAR profile at

www.sedar.com

.

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian and

United States

securities legislation.  All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to future company performance, growth, profitability, competitive position, and acquisition opportunities, the completion of the proposed Transactions, timing for completion of the proposed Transactions, and the Company’s corporate strategy moving forward.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: implications of the COVID-19 pandemic on the Company’s operations; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion and acquisitions; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations; the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates; and the risk factors set out in the Company’s management discussion and analysis for the period ended

September 30, 2021

and the Company’s listing statement dated

May 30, 2019

, which are available under the Company’s profile on

www.sedar.com

. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Company, through several of its subsidiaries, is indirectly involved in the manufacture, possession, use, sale, and distribution of cannabis in the recreational and medicinal cannabis marketplace in

the United States

. Local state laws where the Company operates permit such activities however, investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States.  Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in

the United States

to, among other things, cultivate, distribute or possess cannabis in the United States.  Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in

the United States

may form the basis for prosecution under applicable

United States

federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in

the United States

has trended toward non-enforcement against individuals and businesses that comply with recreational and medicinal cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under

United States

federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company.  The enforcement of federal laws in

the United States

is a significant risk to the business of the Company and any proceedings brought against the Company thereunder may adversely affect the Company’s operations and financial performance.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities in

the United States

. The Company’s securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within

the United States

or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:

https://www.prnewswire.com/news-releases/harborside-inc-announces-departure-of-board-member-301451796.html

SOURCE Harborside Inc.